COVID-19 Treatment Remdesivir to Cost Private Insurers $3,120

The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. …

from News – Insurance Journal https://ift.tt/2ZEpec4